graphic lines 1

Delivering the Power of Sight

Transforming ophthalmology and optometry by addressing the underlying causes of the world’s most prevalent eye diseases.

About the Company

Sight Sciences is a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease.
Founded in 2011, the company has developed, and is now commercial with intelligently designed and engineered products to assist healthcare practitioners where our products are indicated. The company’s product portfolio features the OMNI® Surgical System, that is indicated for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm’s canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's non-surgical product portfolio consists of TearCare® System, which is now commercially available for both ophthalmologists and optometrists. TearCare® is a software-controlled, wearable eyelid technology that is intended for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), when used in conjunction with manual expression of the meibomian glands.
graphic lines 3

OMNI® Surgical System – an implant free device that targets outflow resistance

OMNI® Surgical System – an implant free device that targets outflow resistance

For surgeons, the OMNI® Surgical System is a novel, implant-free MIGS device which can be used in combination with cataract surgery or in a standalone procedure to lower IOP in adult patients with Primary Open Angle Glaucoma.

TearCare® System Personalized Open-Eye Experience

TearCare® System Personalized Open-Eye Experience

The TearCare® System utilizes both wearable and smart technology that is intended for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), when used in conjunction with manual expression of the meibomian glands.
The TearCare<sup>®</sup> System utilizes both wearable and smart technology that is intended for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), when used in conjunction with manual expression of the meibomian glands.
VISIT TEARCARE WEBSITE

News

Inquire

For all inquiries, please complete the following form.

    Area of Interest (check all that apply)
    Submit